$30.03
-0.39-1.28%
Last update: Oct 23, 7:52 PM
Pfizer Inc
PFENYSE
Pfizer (PFE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Pfizer (PFE) last issued guidance on August 4, 2026 for fiscal year 2026. The company guided earnings per share in the range of $2.8 - $3, compared to a consensus EPS estimate of $2.97. Pfizer also guided revenue in the range of $60.5B - $62.5B for the period.
Compared to prior guidance, Pfizer maintained its EPS outlook from a previous range of $2.8 - $3. On the revenue side, the company maintained its revenue forecast from a prior range of $59.5B - $62.5B.
Pfizer has issued 23 guidance updates between November 1, 2022 and August 4, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $0.68 | $0.72 | $0.56 | $0.65 |
| Actual | $0.77 | $0.75 | $0.66 | $0.87 |
| Surprise | +13.2% | +4.17% | +17.9% | +33.9% |
| Revenue | ||||
| Estimate | $14.43B | $13.81B | $16.87B | $16.55B |
| Actual | $15.03B | $14.45B | $17.56B | $16.65B |
| Surprise | +4.22% | +4.68% | +4.08% | +0.61% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $0.73 | $0.71 | $0.85 | $0.70 |
| Revenue | ||||
| Consensus | $15.93B | $16.97B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $0.77 | $0.68 | 13.2 % |
| Q1 | May 5, 2026 | $0.75 | $0.72 | 4.17 % |
| Q4 | Feb 3, 2026 | $0.66 | $0.56 | 17.9 % |
| Q3 | Nov 4, 2025 | $0.87 | $0.65 | 33.9 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 4, 2026 | $15.03B | $14.43B | 4.22 % |
| Q1 | May 5, 2026 | $14.45B | $13.81B | 4.68 % |
| Q4 | Feb 3, 2026 | $17.56B | $16.87B | 4.08 % |
| Q3 | Nov 4, 2025 | $16.65B | $16.55B | 0.61 % |
